- Home
- ATXS vs RFMZ Comparison
ATXS vs RFMZ Comparison
Compare ATXS & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- RFMZ
- Stock Information
- Founded
- ATXS 2008
- RFMZ 2021
- Country
- ATXS United States
- RFMZ United States
- Employees
- ATXS N/A
- RFMZ N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- RFMZ Trusts Except Educational Religious and Charitable
- Sector
- ATXS Health Care
- RFMZ Finance
- Exchange
- ATXS Nasdaq
- RFMZ Nasdaq
- Market Cap
- ATXS 401.2M
- RFMZ 300.5M
- IPO Year
- ATXS 2015
- RFMZ N/A
- Fundamental
- Price
- ATXS $4.48
- RFMZ $12.87
- Analyst Decision
- ATXS Strong Buy
- RFMZ
- Analyst Count
- ATXS 6
- RFMZ 0
- Target Price
- ATXS $30.00
- RFMZ N/A
- AVG Volume (30 Days)
- ATXS 501.6K
- RFMZ 76.6K
- Earning Date
- ATXS 05-20-2025
- RFMZ 01-01-0001
- Dividend Yield
- ATXS N/A
- RFMZ 7.43%
- EPS Growth
- ATXS N/A
- RFMZ N/A
- EPS
- ATXS N/A
- RFMZ 0.65
- Revenue
- ATXS N/A
- RFMZ N/A
- Revenue This Year
- ATXS N/A
- RFMZ N/A
- Revenue Next Year
- ATXS N/A
- RFMZ N/A
- P/E Ratio
- ATXS N/A
- RFMZ $21.49
- Revenue Growth
- ATXS N/A
- RFMZ N/A
- 52 Week Low
- ATXS $3.56
- RFMZ $11.28
- 52 Week High
- ATXS $12.92
- RFMZ $14.57
- Technical
- Relative Strength Index (RSI)
- ATXS 38.86
- RFMZ 52.15
- Support Level
- ATXS $4.25
- RFMZ $12.77
- Resistance Level
- ATXS $5.47
- RFMZ $13.03
- Average True Range (ATR)
- ATXS 0.35
- RFMZ 0.13
- MACD
- ATXS 0.01
- RFMZ 0.09
- Stochastic Oscillator
- ATXS 27.45
- RFMZ 79.22
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.